<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04085367</url>
  </required_header>
  <id_info>
    <org_study_id>RD.06.SPR.112199</org_study_id>
    <nct_id>NCT04085367</nct_id>
  </id_info>
  <brief_title>Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face</brief_title>
  <official_title>A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream in the Treatment of Thin and Moderately Thick, Non-hyperkeratotic, Non-pigmented Actinic Keratosis (AK) of the Face and Scalp When Using Daylight Photodynamic Therapy (DL-PDT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Galderma R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Galderma R&amp;D</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Assess the Efficacy and
      Safety of Methyl aminolevulinate hydrochloride (MAL) 16.8% cream (CD06809-41) versus vehicle
      cream in the treatment of thin and moderately thick, non-hyperkeratotic, non-pigmented
      actinic keratosis of the face and scalp when using daylight photodynamic therapy (DL-PDT)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, double-blind, vehicle-controlled, multicenter, parallel-group study in
      adult subjects with clinically-confirmed mild to moderate AKs on the face and the balding
      scalp, to be conducted at approximately 60 clinical sites in the United States. Sites will be
      selected to ensure that diverse daylight conditions will be represented in the study to
      understand the effects of latitude, elevation, and climate.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 30, 2019</start_date>
  <completion_date type="Anticipated">November 6, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 6, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lesion Response</measure>
    <time_frame>Week 12</time_frame>
    <description>Percent of lesions treated at 2nd DL-PDT in complete response at Week 12</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lesion Complete Response</measure>
    <time_frame>Week 12</time_frame>
    <description>Compare Lesion response between MAL and Vehicle DL-PDT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lesion Partial Response</measure>
    <time_frame>Week 12</time_frame>
    <description>Compare partial clearance of AK</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Self-Assessment of Pain</measure>
    <time_frame>Week 12</time_frame>
    <description>Subject will assess maximum pain felt during day light exposure, where 0 - No Pain and 10 - Extreme Pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">465</enrollment>
  <condition>Actinic Keratoses</condition>
  <arm_group>
    <arm_group_label>Vehicle</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two treatments of Day light DLT two weeks apart</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two treatments of Day light DLT two weeks apart</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MAL 16.8% cream</intervention_name>
    <description>Two treatments of DL-PDT</description>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_label>Vehicle</arm_group_label>
    <other_name>Vehicle</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects aged â‰¥ 18 years at the Screening visit

          -  Subjects have at least 4, but no more than 12, clinically-confirmed thin or moderately
             thick, non-hyperkeratotic, non-pigmented AKs located on the face (e.g., forehead,
             cheek, chin), and balding scalp

          -  Female subjects of non-childbearing potential

          -  Subject fully understands and signs an ICF before any investigational procedure(s) are
             performed

        Exclusion Criteria:

          -  Subjects with pigmented AK in the treatment areas

          -  Female subjects who are pregnant, nursing, or planning a pregnancy during the study

          -  Subjects with a clinical diagnosis of a skin disease other than AK

          -  Immunocompromised subjects

          -  Subjects with any condition that may be associated with a risk of poor protocol
             compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Galderma</last_name>
    <phone>817-961-5000</phone>
    <email>clinical.studies@galderma.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8010)</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205-5067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8010)</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8768)</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8447)</name>
      <address>
        <city>Fort Smith</city>
        <state>Arkansas</state>
        <zip>72916-6103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8577)</name>
      <address>
        <city>Encinitas</city>
        <state>California</state>
        <zip>92024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8636)</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <zip>92708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8224)</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8114)</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8608)</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8778)</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8756)</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8440)</name>
      <address>
        <city>Greenwood Village</city>
        <state>Colorado</state>
        <zip>80111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8479)</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8770)</name>
      <address>
        <city>Lehigh Acres</city>
        <state>Florida</state>
        <zip>33936</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8765)</name>
      <address>
        <city>North Miami Beach</city>
        <state>Florida</state>
        <zip>33162</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigation Site (Site 8769)</name>
      <address>
        <city>Palm Springs</city>
        <state>Florida</state>
        <zip>33461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8734)</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33028</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8529)</name>
      <address>
        <city>Sanford</city>
        <state>Florida</state>
        <zip>32771</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8126)</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8683)</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342-1418</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8667)</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8755)</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8715)</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8724)</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8208)</name>
      <address>
        <city>Beverly</city>
        <state>Massachusetts</state>
        <zip>01915</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8574)</name>
      <address>
        <city>Clarkston</city>
        <state>Michigan</state>
        <zip>48346-3198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigation Site (Site 8757)</name>
      <address>
        <city>Saint Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8762)</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55424-1200</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8219)</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8048)</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8420)</name>
      <address>
        <city>Portsmouth</city>
        <state>New Hampshire</state>
        <zip>03801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8759)</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8242)</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8733)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8279)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8566)</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28277</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8726)</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28405-3176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8595)</name>
      <address>
        <city>Dublin</city>
        <state>Ohio</state>
        <zip>43016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investiational Site (Site 8212)</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210-2996</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8255)</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8721)</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8754)</name>
      <address>
        <city>Sugarloaf</city>
        <state>Pennsylvania</state>
        <zip>18249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8777)</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8207)</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8076)</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78759</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8139)</name>
      <address>
        <city>College Station</city>
        <state>Texas</state>
        <zip>77845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8664)</name>
      <address>
        <city>Frisco</city>
        <state>Texas</state>
        <zip>75034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site # 8576)</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77056</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8546)</name>
      <address>
        <city>Pflugerville</city>
        <state>Texas</state>
        <zip>78660-3519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8776)</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84790</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8672)</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8761)</name>
      <address>
        <city>West Jordan</city>
        <state>Utah</state>
        <zip>84101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8779)</name>
      <address>
        <city>Burien</city>
        <state>Washington</state>
        <zip>98168</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8039)</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8760)</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8725)</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (Site 8231)</name>
      <address>
        <city>Aibonito</city>
        <zip>00705</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>September 9, 2019</study_first_submitted>
  <study_first_submitted_qc>September 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2019</study_first_posted>
  <last_update_submitted>December 9, 2019</last_update_submitted>
  <last_update_submitted_qc>December 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratosis, Actinic</mesh_term>
    <mesh_term>Keratosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

